| 词条 | Pharmaceutical industry in Bangladesh | ||||||||||||||||||
| 释义 |
The pharmaceutical industry in Bangladesh is one of the most developed technology sectors within Bangladesh. Manufacturers produce insulin, hormones, and cancer drugs. This sector provides 97% of the total medicinal requirement of the local market. The industry also exports medicines to global markets, including Europe. Pharmaceutical companies are expanding their business with the aim to expand the export market.[1] There are 5 types of medicine manufacturing companies in Bangladesh.
ProductsThe Industry exports active pharmaceutical ingredients (APIs) and a wide range of pharmaceutical products, covering all major therapeutic classes and dosage forms, to 79 countries. Along with regular forms like tablets, capsules and syrups, Bangladesh also exports specialized products like HFA inhalers, CFC inhalers, suppositories, nasal sprays, injectables, IV infusions, etc. These products have been well accepted by medical practitioners, chemists, patients and the regulatory bodies of all of their importing nations. The packaging and the presentation of the products of Bangladesh are comparable to any international standard. RegulationTwo organizations regulate drugs and pharmacies in Bangladesh. The Directorate General of Drug Administration (DGDA) is the national drug regulatory authority which is under the Ministry of Health and Family Welfare. DGDA regulates all activities related to import and export of raw materials, packaging materials, production, sale, pricing, licensing, registration of all kinds of medicine including those of Ayurvedic, Unani, herbal and homeopathic systems.[2] The Pharmacy Council of Bangladesh(PCB) was established under the Pharmacy Ordinance Act in 1976.[3] to control the pharmacy practice in Bangladesh. The Bangladesh Pharmaceutical Society is affiliated with the International Pharmaceutical Federation and Commonwealth Pharmaceutical Association. The National Drug Policy (2005) states that the World Health Organization’s current Good Manufacturing Practices (GMP) should be strictly followed and that manufacturing units will be regularly inspected by the DDA. Other key regulation features are restrictions on imported drugs (where these are produced by four or more local firms), a ban on local production of around 1,700 drugs that are considered non-essential or harmful and strict price controls on some 117 principal medicines.[4] See also
Notes and references1. ^http://dspace.bracu.ac.bd/bitstream/handle/10361/3220/13274025.pdf?sequence=1 {{Pharmaceutical industry by country}}2. ^{{cite web|url=http://www.dgda.gov.bd/|title=Home|author=|date=|website=www.dgda.gov.bd|accessdate=23 April 2018}} 3. ^{{cite web|url=http://www.pcb.gov.bd/|title=Home|first=Super|last=User|date=|website=www.pcb.gov.bd|accessdate=23 April 2018}} 4. ^Article Novartis Bangladesh Pharmaceutical Marketplace {{webarchive|url=https://web.archive.org/web/20120704194050/http://www.mkazi.net/article-novartis-bangladesh-pharmaceutical-marketplace-analysis.aspx |date=4 July 2012 }} 3 : Pharmaceutical companies of Bangladesh|Industry in Bangladesh|Pharmaceutical industry by country |
||||||||||||||||||
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。